Globus Medical, Inc. (NYSE:GMED) Q4 2023 Earnings Conference Call February 20, 2024 4:30 PM ET

Company Participants

Brian Kearns – Senior Vice President, Business Development and Investor Relations

Daniel Scavilla – President and Chief Executive Officer

Keith Pfeil – Chief Operating Officer and Chief Financial Officer

Conference Call Participants

Vikramjeet Chopra – Wells Fargo Securities

Steven Lichtman – Oppenheimer

Matt Blackman – Stifel

Shagun Singh – RBC Capital Markets

David Saxon – Needham & Company

Matthew Miksic – Barclays Bank

Matthew O’Brien – Piper Sandler & Co.

Matthew Taylor – Jefferies

Ryan Zimmerman – BTIG

Jason Wittes – ROTH MKM Partners

Craig Bijou – Bank of America Merrill Lynch

Caitlin Cronin – Canaccord

Richard Newitter – Truist Securities

Andrew Ranieri – Morgan Stanley


Thank you for standing by, and welcome to the Globus Medical’s Fourth Quarter and Full Year 2023 Earnings Call. [Operator Instructions]. Please be advised that today’s conference is being recorded.

I will now turn the call over to your first speaker today, Brian Kearns, Senior Vice President of Business Development and Investor Relations. Please go ahead.

Brian Kearns

Thank you, Victor, and thank you, everyone, for being with us today. Joining today’s call for Globus Medical will be Dan Scavilla, President and CEO; and Keith Pfeil, Chief Operating and Chief Financial Officer. This review is being made available via webcast accessible through Investor Relations section of the Globus Medical website at

Before we begin, let me remind that some of the statements made during this review are or may be considered forward-looking statements. Our Form 10-K for the 2023 fiscal year and our subsequent filings with the Securities and Exchange Commission identify certain factors that could cause our actual results to differ materially from those projected in any forward-looking statements made today.

Our SEC filings, including

Source link